Neoplasms

All Conditions

Digestive System Diseases

Carcinoma

Carcinoma, Hepatocellular

Neoplasms, Glandular and Epithelial

Neoplasms by Histologic Type

Adenocarcinoma

Liver Neoplasms

Gastrointestinal Neoplasms

Digestive System Neoplasms

Gastrointestinal Diseases

Liver Diseases

Hematinics

All Drugs and Chemicals

Liver Extracts

Contrast-enhanced ultrasound with perfluorobutane and sulfur hexafluoride for the hepatic lesion.

contrast enhanced ultrasound with perfluorobutane and sulfur hexafluoride

contrast enhanced ultrasound

Participants underwent dynamic CT for hepatic lesion

Dynamic CT

Participants underwent liver MRI for hepatic lesion

Liver MRI

Jeong Min Lee, Dr.

Intra-individual comparison of diagnostic performance of CEUS With perfluorobutane and sulfur hexafluoride for HCC in high-risk Individuals, and their role in the diagnostic algorithm of HCC.

The investigators would compare the diagnostic performance for HCC at high-risk individuals between both USG contrast agents.

Study participants underwent contrast-enhanced ultrasound with perfluorobutane and sulfur hexafluoride. The diagnostic performance will be compared intra-individually.

Contrast-enhanced Ultrasound With Perfluorobutane and Sulfur Hexafluoride for Hepatocellular Carcinoma

Perfluorobutane-enhanced Ultrasound as a Diagnostic Tool for Hepatocellular Carcinoma in Individuals With High Risk: Intraindividual Comparison With Sulfur Hexafluoride-enhanced Ultrasound

The number of perfluorobutane enhanced USG diagnosed HCC that were missed by prior gadoxetic-acid MRI to simulate diagnostic algorithm for HCC and reveal the role of PFB-US as a second-line diagnostic modality

The per-lesion diagnostic accuracy for HCC of CEUS with perfluorobutane and sulfur hexafluoride using the same diagnostic criteria (arterial phase hyperenehancement with mild and late (≥ 60 sec) washout).

Per-lesion sensitivity and specificity for diagnosing HCC using different time windows for assessing washout in PFB-US

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Contrast-enhanced Ultrasound With Perfluorobutane and Sulfur Hexafluoride for Hepatocellular Carcinoma	NCT04847726	Hepatocellular ...	contrast enhanc... Dynamic CT Liver MRI	18 Years -	Seoul National University Hospital
Contrast-enhanced Ultrasound With Perfluorobutane and Sulfur Hexafluoride for Hepatocellular Carcinoma	NCT04847726	Hepatocellular ...	contrast enhanc... Dynamic CT Liver MRI	18 Years -	Seoul National University Hospital

Spots Global Cancer Trial Database for liver mri

Every month we try and update this database with for liver mri cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Spots Global Cancer Trial Database for liver mri

Every month we try and update this database with for liver mri cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for liver mri cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.